{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:11:11Z","timestamp":1789229471885,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Heidelberger Stiftung Chirurgie"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCIN 947\/4-2"],"award-info":[{"award-number":["SCIN 947\/4-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3556-2","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T13:20:36Z","timestamp":1503408036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["EMX2 gene expression predicts liver metastasis and survival in colorectal cancer"],"prefix":"10.1186","volume":"17","author":[{"given":"Berk","family":"Aykut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Ochs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Brill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermine","family":"H\u00f6cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Weissinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakup","family":"Kulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"issue":"2","key":"3556_CR1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3322\/caac.21220","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104\u201317.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3556_CR2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ajg.2015.418","volume":"111","author":"J Pan","year":"2016","unstructured":"Pan J, Xin L, Ma YF, Hu LH, Li ZS. Colonoscopy reduces colorectal cancer incidence and mortality in patients with non-malignant findings: a meta-analysis. Am J Gastroenterol. 2016;111(3):355\u201365.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"3556_CR3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1634\/theoncologist.2008-0202","volume":"14","author":"CH Kohne","year":"2009","unstructured":"Kohne CH, Lenz HJ. Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer. Oncologist. 2009;14(5):478\u201388.","journal-title":"Oncologist"},{"issue":"3","key":"3556_CR4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/SLA.0000000000001374","volume":"263","author":"W Chang","year":"2016","unstructured":"Chang W, Wei Y, Ren L, et al. Randomized controlled trial of Intraportal chemotherapy combined with adjuvant chemotherapy (mFOLFOX6) for stage II and III colon cancer. Ann Surg. 2016;263(3):434\u20139.","journal-title":"Ann Surg"},{"issue":"2","key":"3556_CR5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.radonc.2011.04.003","volume":"99","author":"P Manchon-Walsh","year":"2011","unstructured":"Manchon-Walsh P, Borras JM, Espinas JA, Aliste L. Catalonian rectal cancer G. Assessing the effectiveness of a guideline recommendation for pre-operative radiochemotherapy in rectal cancer. Radiother Oncol. 2011;99(2):142\u20137.","journal-title":"Radiother Oncol"},{"issue":"10","key":"3556_CR6","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/annonc\/mds236","volume":"23","author":"HJ Schmoll","year":"2012","unstructured":"Schmoll HJ, Van Cutsem E, Stein A, et al. ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol. 2012;23(10):2479\u2013516.","journal-title":"Ann Oncol"},{"issue":"1","key":"3556_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/excr.1999.4451","volume":"248","author":"C Cillo","year":"1999","unstructured":"Cillo C, Faiella A, Cantile M, Boncinelli E. Homeobox genes and cancer. Exp Cell Res. 1999;248(1):1\u20139.","journal-title":"Exp Cell Res"},{"issue":"2","key":"3556_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1460-9568.2005.04559.x","volume":"23","author":"RM Gangemi","year":"2006","unstructured":"Gangemi RM, Daga A, Muzio L, et al. Effects of Emx2 inactivation on the gene expression profile of neural precursors. Eur J Neurosci. 2006;23(2):325\u201334.","journal-title":"Eur J Neurosci"},{"issue":"10","key":"3556_CR9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrc907","volume":"2","author":"C Abate-Shen","year":"2002","unstructured":"Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer. 2002;2(10):777\u201385.","journal-title":"Nat Rev Cancer"},{"issue":"12A","key":"3556_CR10","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1101\/gad.3.12a.1940","volume":"3","author":"D Dalton","year":"1989","unstructured":"Dalton D, Chadwick R, McGinnis W. Expression and embryonic function of empty spiracles: a drosophila homeo box gene with two patterning functions on the anterior-posterior axis of the embryo. Genes Dev. 1989;3(12A):1940\u201356.","journal-title":"Genes Dev"},{"issue":"7","key":"3556_CR11","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1242\/dev.129.7.1633","volume":"129","author":"R Galli","year":"2002","unstructured":"Galli R, Fiocco R, De Filippis L, et al. Emx2 regulates the proliferation of stem cells of the adult mammalian central nervous system. Development. 2002;129(7):1633\u201344.","journal-title":"Development"},{"issue":"10","key":"3556_CR12","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1242\/dev.00421","volume":"130","author":"KL Ligon","year":"2003","unstructured":"Ligon KL, Echelard Y, Assimacopoulos S, et al. Loss of Emx2 function leads to ectopic expression of Wnt1 in the developing telencephalon and cortical dysplasia. Development. 2003;130(10):2275\u201387.","journal-title":"Development"},{"issue":"5","key":"3556_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2826","volume":"10","author":"N Shah","year":"2010","unstructured":"Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer. 2010;10(5):361\u201371.","journal-title":"Nat Rev Cancer"},{"issue":"44","key":"3556_CR14","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1038\/onc.2010.330","volume":"29","author":"J Okamoto","year":"2010","unstructured":"Okamoto J, Hirata T, Chen Z, et al. EMX2 is epigenetically silenced and suppresses growth in human lung cancer. Oncogene. 2010;29(44):5969\u201375.","journal-title":"Oncogene"},{"issue":"1\u20133","key":"3556_CR15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/geno.2001.6590","volume":"76","author":"FC Noonan","year":"2001","unstructured":"Noonan FC, Mutch DG, Ann Mallon M, Goodfellow PJ. Characterization of the homeodomain gene EMX2: sequence conservation, expression analysis, and a search for mutations in endometrial cancers. Genomics. 2001;76(1\u20133):37\u201344.","journal-title":"Genomics"},{"issue":"9","key":"3556_CR16","doi-asserted-by":"crossref","first-page":"e45970","DOI":"10.1371\/journal.pone.0045970","volume":"7","author":"J Li","year":"2012","unstructured":"Li J, Mo M, Chen Z, et al. Adenoviral delivery of the EMX2 gene suppresses growth in human gastric cancer. PLoS One. 2012;7(9):e45970.","journal-title":"PLoS One"},{"issue":"11","key":"3556_CR17","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1210\/me.2005-0130","volume":"19","author":"HS Taylor","year":"2005","unstructured":"Taylor HS, Fei X. Emx2 regulates mammalian reproduction by altering endometrial cell proliferation. Mol Endocrinol. 2005;19(11):2839\u201346.","journal-title":"Mol Endocrinol"},{"issue":"7","key":"3556_CR18","doi-asserted-by":"crossref","first-page":"e0132134","DOI":"10.1371\/journal.pone.0132134","volume":"10","author":"D Yue","year":"2015","unstructured":"Yue D, Li H, Che J, et al. EMX2 is a predictive marker for adjuvant chemotherapy in lung Squamous cell carcinomas. PLoS One. 2015;10(7):e0132134.","journal-title":"PLoS One"},{"issue":"6","key":"3556_CR19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101\u20138.","journal-title":"Nat Protoc"},{"issue":"1\u20132","key":"3556_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(02)00623-6","volume":"291","author":"C Cecchi","year":"2002","unstructured":"Cecchi C. Emx2: a gene responsible for cortical development, regionalization and area specification. Gene. 2002;291(1\u20132):1\u20139.","journal-title":"Gene"},{"issue":"14","key":"3556_CR21","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1093\/nar\/gks295","volume":"40","author":"J Mariani","year":"2012","unstructured":"Mariani J, Favaro R, Lancini C, et al. Emx2 is a dose-dependent negative regulator of Sox2 telencephalic enhancers. Nucleic Acids Res. 2012;40(14):6461\u201376.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"3556_CR22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.mod.2004.03.013","volume":"121","author":"K Shinozaki","year":"2004","unstructured":"Shinozaki K, Yoshida M, Nakamura M, Aizawa S, Suda Y. Emx1 and Emx2 cooperate in initial phase of archipallium development. Mech Dev. 2004;121(5):475\u201389.","journal-title":"Mech Dev"},{"issue":"7","key":"3556_CR23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/76630","volume":"3","author":"A Mallamaci","year":"2000","unstructured":"Mallamaci A, Muzio L, Chan CH, Parnavelas J, Boncinelli E. Area identity shifts in the early cerebral cortex of Emx2\u2212\/\u2212 mutant mice. Nat Neurosci. 2000;3(7):679\u201386.","journal-title":"Nat Neurosci"},{"issue":"14","key":"3556_CR24","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1242\/dev.129.14.3479","volume":"129","author":"K Shinozaki","year":"2002","unstructured":"Shinozaki K, Miyagi T, Yoshida M, et al. Absence of Cajal-Retzius cells and subplate neurons associated with defects of tangential cell migration from ganglionic eminence in Emx1\/2 double mutant cerebral cortex. Development. 2002;129(14):3479\u201392.","journal-title":"Development"},{"issue":"1","key":"3556_CR25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/ng0196-94","volume":"12","author":"S Brunelli","year":"1996","unstructured":"Brunelli S, Faiella A, Capra V, et al. Germline mutations in the homeobox gene EMX2 in patients with severe schizencephaly. Nat Genet. 1996;12(1):94\u20136.","journal-title":"Nat Genet"},{"issue":"4","key":"3556_CR26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ng1330","volume":"36","author":"H Suzuki","year":"2004","unstructured":"Suzuki H, Watkins DN, Jair KW, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet. 2004;36(4):417\u201322.","journal-title":"Nat Genet"},{"issue":"5","key":"3556_CR27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ncb2048","volume":"12","author":"L Vermeulen","year":"2010","unstructured":"Vermeulen L, De Sousa EMF, van der Heijden M, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol. 2010;12(5):468\u201376.","journal-title":"Nat Cell Biol"},{"issue":"10","key":"3556_CR28","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.18632\/oncotarget.1626","volume":"5","author":"S Ormanns","year":"2014","unstructured":"Ormanns S, Neumann J, Horst D, Kirchner T, Jung A. WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear beta-catenin depend on active PI3K signaling. Oncotarget. 2014;5(10):2999\u20133011.","journal-title":"Oncotarget"},{"issue":"3","key":"3556_CR29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","volume":"127","author":"H Clevers","year":"2006","unstructured":"Clevers H. Wnt\/beta-catenin signaling in development and disease. Cell. 2006;127(3):469\u201380.","journal-title":"Cell"},{"issue":"4","key":"3556_CR30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cllc.2011.03.025","volume":"12","author":"J Okamoto","year":"2011","unstructured":"Okamoto J, Kratz JR, Hirata T, et al. Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients. Clin Lung Cancer. 2011;12(4):237\u201344.","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"3556_CR31","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1124\/pr.111.005637","volume":"64","author":"DW Shen","year":"2012","unstructured":"Shen DW, Pouliot LM, Hall MD, Gottesman MM. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev. 2012;64(3):706\u201321.","journal-title":"Pharmacol Rev"},{"issue":"10","key":"3556_CR32","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1600-0463.2011.02798.x","volume":"119","author":"MS Kim","year":"2011","unstructured":"Kim MS, An CH, Yoo NJ, Lee SH. Rare somatic mutation and loss of expression of EMX2 gene in common solid cancers. APMIS. 2011;119(10):733\u20134.","journal-title":"APMIS"},{"issue":"2","key":"3556_CR33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/SLA.0000000000001341","volume":"263","author":"NN Rahbari","year":"2016","unstructured":"Rahbari NN, Bork U, Scholch S, et al. Metastatic spread emerging from liver metastases of colorectal cancer: does the seed leave the soil again? Ann Surg. 2016;263(2):345\u201352.","journal-title":"Ann Surg"},{"issue":"2","key":"3556_CR34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/157488509788185123","volume":"4","author":"A Sharma","year":"2009","unstructured":"Sharma A, Tandon M, Bangari DS, Mittal SK. Adenoviral vector-based strategies for cancer therapy. Curr Drug ther. 2009;4(2):117\u201338.","journal-title":"Curr Drug ther"},{"issue":"2","key":"3556_CR35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nbt.1769","volume":"29","author":"C Sheridan","year":"2011","unstructured":"Sheridan C. Gene therapy finds its niche. Nat Biotechnol. 2011;29(2):121\u20138.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"3556_CR36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrg2141","volume":"8","author":"R Waehler","year":"2007","unstructured":"Waehler R, Russell SJ, Curiel DT. Engineering targeted viral vectors for gene therapy. Nat Rev Genet. 2007;8(8):573\u201387.","journal-title":"Nat Rev Genet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3556-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T16:17:52Z","timestamp":1659370672000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3556-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3556"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3556-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]},"article-number":"555"}}